The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
112774235 11277423 5 F 2015 20160830 20150716 20160907 EXP US-PFIZER INC-2015233174 PFIZER 77.00 YR F Y 91.00000 KG 20160907 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
112774235 11277423 1 PS XELJANZ TOFACITINIB CITRATE 1 5 MG, 2X/DAY RX 14087159 203214 5 MG TABLET BID
112774235 11277423 2 SS ESTRADIOL. ESTRADIOL 1 1 MG, 1X/DAY Y 0 1 MG QD
112774235 11277423 3 SS ESTRADIOL. ESTRADIOL 1 1 MG, 3 TIMES A WEEK Y 0 1 MG
112774235 11277423 4 C LOSARTAN AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM 1 [25MG]/[ 100MG] 1X/DAY 0 QD
112774235 11277423 5 C ROPINIROLE. ROPINIROLE 1 4 MG, 2X/DAY 0 4 MG BID
112774235 11277423 6 C ACYCLOVIR. ACYCLOVIR 1 400 MG, 1X/DAY 0 400 MG QD
112774235 11277423 7 C METFORMIN METFORMIN HYDROCHLORIDE 1 500 MG 3 TABS A DAY 0 1500 MG TABLET
112774235 11277423 8 C GLIMEPIRIDE. GLIMEPIRIDE 1 2 MG, 1X/DAY 0 2 MG QD
112774235 11277423 9 C FOLIC ACID. FOLIC ACID 1 800 MG, 1X/DAY 0 800 MG QD
112774235 11277423 10 C VITAMIN B12 CYANOCOBALAMIN 1 1000 MG, 1X/DAY 0 1000 MG QD
112774235 11277423 11 C AMLODIPINE AMLODIPINE BESYLATE 1 10 MG, 1X/DAY 0 10 MG QD
112774235 11277423 12 C LEVOTHYROXINE. LEVOTHYROXINE 1 150 UG, 1X/DAY 0 150 UG QD
112774235 11277423 13 C ASPIRIN. ASPIRIN 1 81 MG, 1X/DAY 0 81 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
112774235 11277423 1 Rheumatoid arthritis
112774235 11277423 2 Hormone replacement therapy
112774235 11277423 3 Hot flush
112774235 11277423 4 Blood pressure abnormal
112774235 11277423 5 Restless legs syndrome
112774235 11277423 6 Oral herpes
112774235 11277423 7 Diabetes mellitus
112774235 11277423 8 Blood glucose increased

Outcome of event

Event ID CASEID OUTC COD
112774235 11277423 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
112774235 11277423 Amnesia
112774235 11277423 Gastrointestinal viral infection
112774235 11277423 Haemoglobin decreased
112774235 11277423 Heart rate increased
112774235 11277423 Insomnia
112774235 11277423 Sleep apnoea syndrome
112774235 11277423 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
112774235 11277423 1 201503 0
112774235 11277423 2 2000 0